The findings also indicate that immunisation protection against severe Covid did not deteriorate during the course of the trial, which lasted up to five months

New Delhi: The government has authorised the export of Russia’s single-dose COVID-19 vaccine Sputnik Light, which is manufactured in India, because the vaccine has not yet been licenced for emergency use in India, according to sources on Sunday.

Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India’s anti-COVID inoculation programme after getting emergency use authorisation from India’s Drug Regulator in April.

The Russian ambassador had urged the Indian government to allow the export of  Sputnik Light produced by Hetero Biopharma, one of the partners of the Russian Direct Investment Fund (RDIF) in the production of the jab, to his country till the vaccine gets emergency use authorisation from India’s drug regulator.

Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India’s anti-COVID inoculation programme after getting emergency use authorisation from India’s Drug Regulator in April.

The Russian ambassador had urged the Indian government to allow the export of  Sputnik Light produced by Hetero Biopharma, one of the partners of the Russian Direct Investment Fund (RDIF) in the production of the jab, to his country till the vaccine gets emergency use authorisation from India’s drug regulator.

In a communication to the Centre, Russian Ambassador Nicholay Kudashev had stated that Hetero Biopharma Limited already has manufactured one million doses of Component 1 of the Sputnik V and two million doses of the Sputnik Light but the six-month shelf life of the vaccine may expire before its registration which will result in the wastage of vaccine doses, sources said.

“The government has permitted Indian drug firm Hetero Biopharma to export 40 lakh doses of Sputnik Light to Russia. The decision was taken this week following detailed deliberations,” a source said.

Over the past months, the RDIF has been working closely with Indian pharmaceutical companies to ramp up the production of Sputnik vaccine in India that could be used in the local and global markets, the ambassador had stated in his communication last month.
At the moment RDIF together with Dr Reddy’s Laboratories is working with authorities concerned on the registration of the Sputnik Light in India.

Medically Speaking

Recent Posts

Head Injuries Linked to Herpes Reactivation and Alzheimer’s Risk: New Study

Head injuries are well-known for causing a range of immediate physical injuries, such as concussions…

14 hours ago

Missing the Mark: Why Many Kids Aren’t Getting the Mental Health Help They Need

Mental health issues among children and young people have become a growing concern worldwide. While…

14 hours ago

COVID’s Silent Grip: Still Deadly, 5 Years Later

The COVID-19 pandemic that once gripped the world has largely faded from daily headlines, but…

15 hours ago

Is Fluoride in Water Lowering Kids’ IQ? New Study Sparks Debate

Fluoride, a mineral added to drinking water in many countries to prevent tooth decay, has…

15 hours ago

Evening Workouts: Good or Bad for Your Health?

https://youtu.be/D83OHJ30Ib8?si=AywW6i6l0XZPruK0 When it comes to fitness, one of the most common debates revolves around the…

15 hours ago

Better Detection, Not More Viruses: The Real Reason Behind the Surge in Viral News

The world has been witnessing an unprecedented increase in the number of viral outbreaks and…

2 days ago